Thursday, July 2, 2015

PPD to expand former Merck vaccine-testing lab in Wayne

The contract research organization is planning a $25 million expansion that would retain 80 jobs and create 86 within three years.

PPD to expand former Merck vaccine-testing lab in Wayne


PPD Inc., a North Carolina-based contract research organization, plans to expand a Tredyffrin Township laboratory it bought from Merck & Co. Inc. at the end of 2008 and create 86 jobs.

The Pennsylvania Department of Community and Economic Development announced Wednesday that the state would provide $608,000 in funding for a $25 million project planned by PPD.

When PPD acquired the 130,000-square-foot vaccine-testing laboratory in Chester County from Merck, it hired the lab's 80 employees. According to a statement issued by the state, PPD intends to renovate the lab at 466 Devon Park Drive, buy new equipment and provide employee training.

The company would create at least 86 jobs within three years, according to the state.

Under its transaction with Merck, PPD agreed to supply testing services to Merck for five years. According to PPD's 2008 annual report, it paid $25.2 million for Merck's lab.

With revenues of $1.42 billion in 2009, PPD is one of the largest providers of outsourced services to the pharmaceutical industry. It employs more than 10,500 people worldwide.

"With a large concentration of pharmaceutical and biotechnology companies based in the northeastern United States, expanding our laboratory operations in Wayne builds on our ability to serve clients in this region more effectively," said Lee Babiss, PPD's executive vice president of global laboratory services, in the statement.

Pennsylvania provided a $275,000 opportunity grant, $74,700 in job training assistance, and $258,000 in job creation tax credits.

PPD shares were trading at $25.77, down 14 cents after 3 p.m.

Inquirer Columnist
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy: comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
comments powered by Disqus
About this blog
Mike Armstrong blogs about Philadelphia corporations and business-related topics. Contact him at 215-854-2980. Reach Mike at

Mike Armstrong Inquirer Columnist
Also on
letter icon Newsletter